321 related articles for article (PubMed ID: 38308498)
41. Liquid biopsy in lymphoma: Molecular methods and clinical applications.
Cirillo M; Craig AFM; Borchmann S; Kurtz DM
Cancer Treat Rev; 2020 Dec; 91():102106. PubMed ID: 33049623
[TBL] [Abstract][Full Text] [Related]
42. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
[TBL] [Abstract][Full Text] [Related]
43. Liquid biopsy in ovarian cancer.
Giannopoulou L; Lianidou ES
Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
[TBL] [Abstract][Full Text] [Related]
44. Refining Cancer Management Using Integrated Liquid Biopsy.
Qiu J; Xu J; Zhang K; Gu W; Nie L; Wang G; Luo Y
Theranostics; 2020; 10(5):2374-2384. PubMed ID: 32089746
[TBL] [Abstract][Full Text] [Related]
45. Liquid biopsy = Individualized cancer management: Diagnosis, monitoring treatment and checking recurrence and metastasis.
Mali SB; Dahivelkar S
Oral Oncol; 2021 Dec; 123():105588. PubMed ID: 34744021
[TBL] [Abstract][Full Text] [Related]
46. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Cheng F; Su L; Qian C
Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
[TBL] [Abstract][Full Text] [Related]
47. Liquid Biopsy in Solid Malignancy.
Scarlotta M; Simsek C; Kim AK
Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
[TBL] [Abstract][Full Text] [Related]
48. Cancer diagnosis: from tumor to liquid biopsy and beyond.
Vaidyanathan R; Soon RH; Zhang P; Jiang K; Lim CT
Lab Chip; 2018 Dec; 19(1):11-34. PubMed ID: 30480287
[TBL] [Abstract][Full Text] [Related]
49. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.
Bunda S; Zuccato JA; Voisin MR; Wang JZ; Nassiri F; Patil V; Mansouri S; Zadeh G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925295
[TBL] [Abstract][Full Text] [Related]
50. Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.
Cani AK; Dolce EM; Darga EP; Hu K; Liu CJ; Pierce J; Bradbury K; Kilgour E; Aung K; Schiavon G; Carroll D; Carr TH; Klinowska T; Lindemann J; Marshall G; Rowlands V; Harrington EA; Barrett JC; Sathiyayogan N; Morrow C; Sero V; Armstrong AC; Baird R; Hamilton E; Im SA; Jhaveri K; Patel MR; Dive C; Tomlins SA; Udager AM; Hayes DF; Paoletti C
Mol Oncol; 2022 May; 16(10):1969-1985. PubMed ID: 34866317
[TBL] [Abstract][Full Text] [Related]
51. A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance.
Nicolazzo C; Gazzaniga P
Methods Mol Biol; 2022; 2535():93-104. PubMed ID: 35867225
[TBL] [Abstract][Full Text] [Related]
52. Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine.
Kerachian MA; Poudineh A; Thiery JP
Crit Rev Oncol Hematol; 2019 Dec; 144():102827. PubMed ID: 31715326
[TBL] [Abstract][Full Text] [Related]
53. Next-Generation Novel Noninvasive Cancer Molecular Diagnostics Platforms Beyond Tissues.
Wu X; Zhu L; Ma PC
Am Soc Clin Oncol Educ Book; 2018 May; 38(38):964-977. PubMed ID: 30231325
[TBL] [Abstract][Full Text] [Related]
54. Liquid Biopsy: From Basic Research to Clinical Practice.
Macías M; Alegre E; Díaz-Lagares A; Patiño A; Pérez-Gracia JL; Sanmamed M; López-López R; Varo N; González A
Adv Clin Chem; 2018; 83():73-119. PubMed ID: 29304904
[TBL] [Abstract][Full Text] [Related]
55. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA.
Giannopoulou L; Kasimir-Bauer S; Lianidou ES
Clin Chem Lab Med; 2018 Jan; 56(2):186-197. PubMed ID: 28753534
[TBL] [Abstract][Full Text] [Related]
56. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
57. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
58. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
[TBL] [Abstract][Full Text] [Related]
59. Single tube liquid biopsy for advanced non-small cell lung cancer.
de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
[TBL] [Abstract][Full Text] [Related]
60. [Circulating Tumor DNA (ctDNA) Detection Using BEAMing and Its Clinical Significance.].
Nakamura K
Rinsho Byori; 2016 May; 64(4):400-406. PubMed ID: 29182806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
